During the last session, Bioline Rx Ltd ADR (NASDAQ:BLRX)’s traded shares were 0.58 million, with the beta value of the company hitting 1.52. At the end of the trading day, the stock’s price was $0.61, reflecting an intraday gain of 6.31% or $0.03. The 52-week high for the BLRX share is $2.53, that puts it down -314.75 from that peak though still a striking 8.2% gain since the share price plummeted to a 52-week low of $0.56. The company’s market capitalization is $48.89M, and the average trade volume was 422.40K shares over the past three months.
Bioline Rx Ltd ADR (NASDAQ:BLRX) trade information
Bioline Rx Ltd ADR (BLRX) registered a 6.31% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 6.31% in intraday trading to $0.61, hitting a weekly high. The stock’s 5-day price performance is -6.84%, and it has moved by -44.90% in 30 days. Based on these gigs, the overall price performance for the year is -43.37%.
Bioline Rx Ltd ADR (BLRX) estimates and forecasts
Statistics show that Bioline Rx Ltd ADR has underperformed its competitors in share price, compared to the industry in which it operates. Bioline Rx Ltd ADR (BLRX) shares have gone down -53.67% during the last six months, with a year-to-date growth rate less than the industry average at -9.57% against 10.40. In the rating firms’ projections, revenue will increase 199.20% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 340k as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 470k by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 21.53%. While earnings are projected to return -15.02% in 2024.
BLRX Dividends
Bioline Rx Ltd ADR is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
